HK Inno.N Corp.
HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hyperc… Read more
Market Cap & Net Worth: HK Inno.N Corp. (195940)
HK Inno.N Corp. (KQ:195940) has a market capitalization of $971.29 Million (₩1.42 Trillion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #10156 globally and #235 in its home market, demonstrating a 3.40% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HK Inno.N Corp.'s stock price ₩50200.00 by its total outstanding shares 28329891 (28.33 Million).
HK Inno.N Corp. Market Cap History: 2021 to 2026
HK Inno.N Corp.'s market capitalization history from 2021 to 2026. Data shows change from $999.51 Million to $971.29 Million (-6.08% CAGR).
Index Memberships
HK Inno.N Corp. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.31% | #64 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.31% | #64 of 1384 |
Weight: HK Inno.N Corp.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
HK Inno.N Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HK Inno.N Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
HK Inno.N Corp.'s market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
HK Inno.N Corp.'s market cap is 0.01 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $999.51 Million | $769.79 Billion | $24.74 Billion | 0.00x | 0.04x |
| 2022 | $711.25 Million | $846.52 Billion | $38.13 Billion | 0.00x | 0.02x |
| 2023 | $860.03 Million | $828.91 Billion | $47.20 Billion | 0.00x | 0.02x |
| 2024 | $693.64 Million | $897.14 Billion | $61.58 Billion | 0.00x | 0.01x |
Competitor Companies of 195940 by Market Capitalization
Companies near HK Inno.N Corp. in the global market cap rankings as of March 18, 2026.
Key companies related to HK Inno.N Corp. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
HK Inno.N Corp. Historical Marketcap From 2021 to 2026
Between 2021 and today, HK Inno.N Corp.'s market cap moved from $999.51 Million to $ 971.29 Million, with a yearly change of -6.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩971.29 Million | +1.83% |
| 2025 | ₩953.87 Million | +37.52% |
| 2024 | ₩693.64 Million | -19.35% |
| 2023 | ₩860.03 Million | +20.92% |
| 2022 | ₩711.25 Million | -28.84% |
| 2021 | ₩999.51 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of HK Inno.N Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $971.29 Million USD |
| MoneyControl | $971.29 Million USD |
| MarketWatch | $971.29 Million USD |
| marketcap.company | $971.29 Million USD |
| Reuters | $971.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.